About LA JOLLA PHARMACEUTICAL COMPANY
Innoviva Specialty Therapeutics develops and delivers innovative therapies for patients in critical care and infectious disease, focusing on urgent medical needs and high unmet conditions.
Developing and delivering innovative therapies for critical care and infectious diseasesResearch and development of new and established standards for critical care and infectious disease treatmentsPipeline of investigational antibiotics, including first-in-class treatments for emerging illnesses
Is this your company?
Claim LA JOLLA PHARMACEUTICAL COMPANY to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim LA JOLLA PHARMACEUTICAL COMPANY & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.